Sriram Yennurajalingam1, Supakarn Tayjasanant1,2, Dave Balachandran3, Nikhil S Padhye4, Janet L Williams1, Diane D Liu5, Susan Frisbee-Hume1, Eduardo Bruera1. 1. 1 Department of Palliative Care and Rehabilitation Medicine, Unit 1414, The University of Texas MD Anderson Cancer Center , Houston, Texas. 2. 2 Siriraj Palliative Care Center, Faculty of Medicine Siriraj Hospital, Mahidol University , Bangkok, Thailand . 3. 4 Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center , Houston, Texas. 4. 5 Research Center for Nursing Research, University of Texas Health School of Nursing, Houston, Texas. 5. 3 Department of Biostatistics, The University of Texas MD Anderson Cancer Center , Houston, Texas.
Abstract
BACKGROUND: There is limited research in advanced cancer patients (ACP) regarding association between objectively measured daytime activity and sleep (as measured by actigraphy), patient characteristics, and cancer symptoms (fatigue, sleep, anxiety, depression, cachexia, and symptom distress scores [SDSs]). OBJECTIVES: Our aim of the study was to determine the association between mean daytime activity (MDTA) and the following items: fatigue (FACIT-F), SDSs (Edmonton Symptom Assessment Scale [ESAS]), sleep quality (Pittsburg Sleep Quality Index [PSQI]), objective sleep variables (OSV) (sleep onset, sleep efficacy, wake after sleep onset, total sleep time), anxiety and depression (Hospital Anxiety and Depression Scale [HADS]), body composition scores, and overall survival (OS). We also examined the association between sleep [PSQI and OSV scores] and FACIT-F, HADS, and ESAS. METHODS: Secondary analysis of a recent clinical trial of cancer-related fatigue in advanced cancer (NCT00424099). Association between MDTA and OSV (measured by actigraphy) during the first week of the study and patient characteristics, symptoms (FACIT-F, ESAS, HADS, and PSQI), and OS were analyzed. RESULTS: Seventy-nine eligible patients were evaluable. The median age was 57 years. Median MDTA was 248.43 counts/minute. Multivariate analysis shows that low MDTA was significantly associated with age, gender, Functional Assessment of Cancer Therapy (FACT)-Functional Well-Being (FWB), ESAS dyspnea, HADS-anxiety, and total sleep time. MDTA was not associated with FACIT-F (p = 0.997) and OS (p = 0.18). Sleep quality (PSQI) was significantly associated with FACIT-F, HADS, ESAS anxiety, and depression, but none of these variables was associated with OSV. CONCLUSION: In ACP, lower MDTA was significantly associated with age, gender, FACT-FWB, ESAS dyspnea, HADS-anxiety, and total sleep time. Both sleep quality and cancer-related fatigue scores were strongly associated with depression and anxiety. More research is needed.
BACKGROUND: There is limited research in advanced cancerpatients (ACP) regarding association between objectively measured daytime activity and sleep (as measured by actigraphy), patient characteristics, and cancer symptoms (fatigue, sleep, anxiety, depression, cachexia, and symptom distress scores [SDSs]). OBJECTIVES: Our aim of the study was to determine the association between mean daytime activity (MDTA) and the following items: fatigue (FACIT-F), SDSs (Edmonton Symptom Assessment Scale [ESAS]), sleep quality (Pittsburg Sleep Quality Index [PSQI]), objective sleep variables (OSV) (sleep onset, sleep efficacy, wake after sleep onset, total sleep time), anxiety and depression (Hospital Anxiety and Depression Scale [HADS]), body composition scores, and overall survival (OS). We also examined the association between sleep [PSQI and OSV scores] and FACIT-F, HADS, and ESAS. METHODS: Secondary analysis of a recent clinical trial of cancer-related fatigue in advanced cancer (NCT00424099). Association between MDTA and OSV (measured by actigraphy) during the first week of the study and patient characteristics, symptoms (FACIT-F, ESAS, HADS, and PSQI), and OS were analyzed. RESULTS: Seventy-nine eligible patients were evaluable. The median age was 57 years. Median MDTA was 248.43 counts/minute. Multivariate analysis shows that low MDTA was significantly associated with age, gender, Functional Assessment of Cancer Therapy (FACT)-Functional Well-Being (FWB), ESAS dyspnea, HADS-anxiety, and total sleep time. MDTA was not associated with FACIT-F (p = 0.997) and OS (p = 0.18). Sleep quality (PSQI) was significantly associated with FACIT-F, HADS, ESAS anxiety, and depression, but none of these variables was associated with OSV. CONCLUSION: In ACP, lower MDTA was significantly associated with age, gender, FACT-FWB, ESAS dyspnea, HADS-anxiety, and total sleep time. Both sleep quality and cancer-related fatigue scores were strongly associated with depression and anxiety. More research is needed.
Authors: Max Dahele; Richard J E Skipworth; Lucy Wall; Anne Voss; Tom Preston; Kenneth C H Fearon Journal: J Pain Symptom Manage Date: 2007-03-23 Impact factor: 3.612
Authors: Aaron J Grossberg; Elisabeth G Vichaya; Diana L Christian; Jessica M Molkentine; Daniel W Vermeer; Phillip S Gross; Paola D Vermeer; John H Lee; Robert Dantzer Journal: Cancer Res Date: 2017-12-07 Impact factor: 12.701
Authors: Ashley M Nelson; Kelly A Hyland; Brent Small; Brittany Kennedy; Asmita Mishra; Aasha I Hoogland; Hailey W Bulls; Heather S L Jim; Paul B Jacobsen Journal: Ann Behav Med Date: 2021-08-23
Authors: R Lobefaro; S Rota; L Porcu; C Brunelli; S Alfieri; E Zito; I Taglialatela; M Ambrosini; A Spagnoletti; M Zimatore; G Fatuzzo; F Lavecchia; C Borreani; G Apolone; F De Braud; M Platania Journal: ESMO Open Date: 2022-03-31
Authors: Eida M Castro-Figueroa; Normarie Torres-Blasco; Milagros C Rosal; Julio C Jiménez; Wallesca P Castro-Rodríguez; Marilis González-Lorenzo; Héctor Vélez-Cortés; Alia Toro-Bahamonde; Rosario Costas-Muñiz; Guillermo N Armaiz-Peña; Heather Jim Journal: Nurs Rep Date: 2021-06-09
Authors: Chelsea G Ratcliff; Stephanie G Zepeda; Martica H Hall; Emily A Tullos; Shaelyn Fowler; Alejandro Chaoul; Amy Spelman; Banu Arun; Lorenzo Cohen Journal: Support Care Cancer Date: 2020-09-22 Impact factor: 3.603
Authors: Sriram Yennurajalingam; Karen Basen-Engquist; James M Reuben; Bryan M Fellman; Sanjay Shete; Rama Maddi; Janet L Williams; Rony Dev; David Hui; Eduardo Bruera Journal: Support Care Cancer Date: 2021-07-31 Impact factor: 3.603
Authors: Pasquale F Innominato; Sandra Komarzynski; Oxana G Palesh; Robert Dallmann; Georg A Bjarnason; Sylvie Giacchetti; Ayhan Ulusakarya; Mohamed Bouchahda; Mazen Haydar; Annabelle Ballesta; Abdoulaye Karaboué; Nicholas I Wreglesworth; David Spiegel; Francis A Lévi Journal: Cancer Med Date: 2018-08-07 Impact factor: 4.452